AG
PDLI

Advisor Group’s PDL BioPharma, Inc. PDLI Stock Holding History

Advisor Group’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$31K Buy
9,451
+500
+6% +$1.45K ﹤0.01% 3724
2019
Q3 		$19K Sell
8,951
-1,500
-14% -$4.01K ﹤0.01% 4007
2019
Q2 		$34K Buy
10,451
+5,050
+94% +$16.4K ﹤0.01% 3639
2019
Q1 		$20K Buy
5,401
+2,968
+122% +$10K ﹤0.01% 3998
2018
Q4 		$7K Sell
2,433
-2,025
-45% -$5.56K ﹤0.01% 4413
2018
Q3 		$12K Buy
4,458
+300
+7% +$736 ﹤0.01% 4216
2018
Q2 		$10K Buy
4,158
+2,000
+93% +$5.58K ﹤0.01% 4101
2018
Q1 		$6K Sell
2,158
-2,251
-51% -$6.14K ﹤0.01% 4375
2017
Q4 		$13K Sell
4,409
-290
-6% -$891 ﹤0.01% 3967
2017
Q3 		$16K Buy
4,699
+1,540
+49% +$4.28K ﹤0.01% 3715
2017
Q2 		$7K Sell
3,159
-32
-1% -$74 ﹤0.01% 4139
2017
Q1 		$7K Buy
3,191
+251
+9% +$555 ﹤0.01% 4009
2016
Q4 		$7K Sell
2,940
-10
-0.3% -$28 ﹤0.01% 3813
2016
Q3 		$10K Sell
2,950
-102,116
-97% -$324K ﹤0.01% 3588
2016
Q2 		$328K Buy
+105,066
New +$350K 0.01% 1154

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Advisor Group's PDLI Position: Q4 2019 in Review

Advisor Group increased its PDL BioPharma, Inc. (PDLI) stake by 5.6% in Q4 2019, buying an estimated $1.45K and bringing the position to 9,451 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #3724.

Advisor Group first reported a position in PDLI in Q2 2016 and has held it in 15 quarters since. The position peaked at $328K in Q2 2016. 150 funds tracked by Wall St. Rank hold PDLI as of Q4 2019.

  • Advisor Group held 9,451 shares of PDL BioPharma, Inc. worth $31K as of Q4 2019.
  • Advisor Group bought 500 PDL BioPharma, Inc. shares in Q4 2019, an estimated $1.45K.
  • PDL BioPharma, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3724 holding.
  • Advisor Group first reported a position in PDL BioPharma, Inc. in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's PDL BioPharma, Inc. position peaked at $328K in Q2 2016.
  • 150 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.